The Scleroderma Foundation Becomes a 2008 Associate Sponsor of the Team Rensi Motorsports/Smithfield #25 Ford in the NASCAR Nationwide Series

The Scleroderma Foundation and Team Rensi Motorsports are proud to announce that the Scleroderma Foundation will be an associate sponsor of the Team Rensi Motorsports/Smithfield #25 Ford Fusion with driver Bobby Hamilton Jr. during the 2008 NASCAR Nationwide Series campaign.

Danvers, MA (PRWEB) March 12, 2008 -- We are most pleased to announce that the Scleroderma Foundation has renewed its associate sponsorship of the Team Rensi Motorsports/Smithfield #25 Ford Fusion with driver Bobby Hamilton Jr. during the 2008 NASCAR Nationwide Series campaign.

"With Bobby Hamilton Jr. and Team Rensi Motorsports, we are certain that our members and all fans of the NASCAR Nationwide Series will see exciting racing," said Frannie Waldron, President and CEO of the Scleroderma Foundation headquartered in Danvers, MA. "Team Rensi Motorsports is a great racing organization and we are confident that Bobby will be great spokesperson for NASCAR racing and all their sponsors and that all NASCAR fans will continue to support this outstanding race team. It is also a great way to raise awareness and funds for this devastating autoimmune disease that affects over 300,000 people in the United States alone. We wish Bobby and the entire #25 Team Rensi Motorsports/Smithfield crew much success in 2008."

For all races, official practices and other appearances in conjunction with races, The Scleroderma Foundation logo will appear on both B-posts of the #25 Rensi Motorsport/Smithfield car as well as on Bobby's uniform, the crew uniforms, the transporter and all collateral promotional items.

About The Scleroderma Foundation:

Their mission is three-pronged:

•    to raise funds for research on the cause and treatment of scleroderma

•    to help patients and their families cope with the disease through mutual support programs and hotline assistance

•    to educate patients and their families as well as medical professionals and the public through medical symposiums, literature, a newsletter, public awareness programs and political advocacy

Unfortunately, as great strides are being made for the treatment and cure of many diseases, scleroderma still remains relatively unknown to the general public. As you may be aware, scleroderma, a devastating autoimmune disease that hardens the skin and often attacks internal organs, affects over 300,000 U.S. citizens. Because it is a disease that receives so little attention, it is important to consider these facts:

•    80% of scleroderma patients are women between the ages of 25 and 55, frequently during childbearing years, (5,000 to 7,000 children suffer with either the linear or morphea form of pediatric scleroderma)

•    The localized and systemic forms of the disease can cause serious facial changes, disfigurement and even death

•    the cause of scleroderma is unknown and currently there is no cure

•    annual direct and indirect costs of scleroderma in the United States are $1.5 billion, according to a study abstract published in Seminars in Arthritis and Rheumatism, and

•    50 million Americans suffer from an autoimmune disease

About Sixx Media:

Sixx Media LLC, is a full-service marketing firm headquartered in the northeast with a satellite office in South Carolina that deals exclusively with NASCAR and other motorsport sponsorships.

For more information about Scleroderma, call toll free at 1-800-722-HOPE (4673) or log on to their website www.scleroderma.org

For information regarding Sixx Media LLC or this announcement, call toll free at 1-888-250-3343.

###


Contact Information
LEONARD JOHNSEN
SIXX Media, LLC
848-565-5789
http://www.scleroderma.org

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy